Literature DB >> 15747107

Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402.

B Balkau, T Hillier, E Vierron, A D'Hour, P Lépinay, B Royer, C Born.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15747107     DOI： 10.1007/s00125-005-1695-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease.

Authors:  E Shyong Tai; Su Yen Goh; Jeannette J M Lee; Moh-Sim Wong; Derrick Heng; Kenneth Hughes; Suok Kai Chew; Jeffery Cutter; William Chew; Ken Gu; Kee Seng Chia; Chee Eng Tan
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

3.  Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions - The MONICA study 1995-97.

Authors:  P Gourdy; J B Ruidavets; J Ferrieres; P Ducimetiere; P Amouyel; D Arveiler; D Cottel; N Lamamy; A Bingham; H Hanaire-Broutin
Journal:  Diabetes Metab       Date:  2001-06       Impact factor: 6.041

4.  [Epidemiology of diabetes in metropolitan France].

Authors:  P Ricordeau; A Weill; N Vallier; R Bourrel; P Fender; H Allemand
Journal:  Diabetes Metab       Date:  2000-09       Impact factor: 6.041

5.  Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia.

Authors:  K Borch-Johnsen; S Colagiuri; B Balkau; C Glümer; B Carstensen; A Ramachandran; Y Dong; W Gao
Journal:  Diabetologia       Date:  2004-07-24       Impact factor: 10.122

6.  High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius.

Authors:  S Söderberg; P Zimmet; J Tuomilehto; M de Courten; G K Dowse; P Chitson; H Stenlund; H Gareeboo; K G M M Alberti; J Shaw
Journal:  J Intern Med       Date:  2004-07       Impact factor: 8.989

7.  The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia.

Authors:  E Barrett-Connor
Journal:  Am J Epidemiol       Date:  1980-06       Impact factor: 4.897

8.  Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112
  8 in total
  4 in total

1.  Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort.

Authors:  T A Hillier; A Fagot-Campagna; E Eschwège; S Vol; M Cailleau; B Balkau
Journal:  Int J Epidemiol       Date:  2005-12-22       Impact factor: 7.196

2.  Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study.

Authors:  Dorte Vistisen; Daniel R Witte; Eric J Brunner; Mika Kivimäki; Adam Tabák; Marit E Jørgensen; Kristine Færch
Journal:  Diabetes Care       Date:  2018-02-16       Impact factor: 19.112

3.  The relationship of abdominal girth with blood pressure, blood sugar and lipid profile among cardiac patients.

Authors:  Sasmita Das; Nikee Minz; Mahesh C Sahu
Journal:  J Taibah Univ Med Sci       Date:  2016-11-15

4.  Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged ≥45 years.

Authors:  Xiaohui Zhuo; Ping Zhang; Henry S Kahn; Edward W Gregg
Journal:  Diabetes Care       Date:  2013-10-17       Impact factor: 19.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.